Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric Zylet Safety and Efficacy Study
NCT00420628Phase 4Completed
- Sponsor
- Bausch + Lomb
- Start
- Nov 2006
- Primary completion
- Jan 2009
- Modality
- Orthosteric Ligands, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of loteprednol etabonate + tobramycin in chalazion, hordeolum, sponsored by Bausch + Lomb. Started Nov 2006; status: completed.
02
Drugs
loteprednol etabonate + tobramycin
03
Conditions
chalazionhordeolum
Beyond the preview
Go deeper on NCT00420628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420628.